{"date": "2025-05-30", "ticker": "Amazon", "triples": [["The New York Times", "is allowing", "Amazon.com to use its editorial content for AI products"], ["The New York Times", "signed", "multi-year agreement with Amazon"], ["Amazon", "will use", "news articles from The Times, NYT Cooking, and The Athletic"], ["The New York Times", "recorded", "$4.4 million in pretax litigation costs in Q1 related to copyright lawsuit"], ["The New York Times", "sued", "Microsoft and OpenAI for copyright infringement"], ["Novo Nordisk", "facing", "request for hundreds of thousands of dollars in attorney fees"], ["Novo Nordisk", "lawsuit against Brooksville Pharmaceuticals", "dismissed"], ["Obesity drug market", "could be worth", "$150 billion by the early 2030s"], ["Novo Nordisk", "filed", "nearly 120 lawsuits across 34 states"], ["Wegovy and Ozempic", "were on", "FDA shortage list from March 2022 to February 2025"], ["Aroundtown", "tripled", "its first-quarter profit"], ["Aroundtown", "is planning to convert", "office spaces into data centres"], ["Aroundtown", "has been facing", "higher vacancy rates in its office spaces"], ["Aroundtown", "expects", "serviced apartments to enter operation in 2026"], ["Aroundtown", "received", "one regulatory permit to convert an office space into a data centre in Frankfurt"], ["Shein", "plans to file", "draft prospectus with Hong Kong's stock exchange in the coming weeks"], ["Shein", "aims to go public", "in Hong Kong within the year"], ["Shein", "had not yet received approval for", "its London IPO from Chinese regulators"], ["Shein", "was set to cut its valuation", "to around $50 billion in a potential London listing"], ["E-commerce packages from China", "are subject to", "a minimum tariff of 30% in the US"]]}